Navigation Links
Antigen Express' AE37 Cancer Vaccine Featured in Scientific American
Date:9/21/2011

ration

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases.  Antigen Express has pioneered the use of specific CD4+ T-helper stimulation in immunotherapy.  One of its platform technologies relies on inhibition of expression of the Ii protein.  Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and prevents the further growth of cancer cells.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequentl
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
2. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
3. Medicago succesfully expresses VLP antigen for A H1N1 strain
4. ImmunoVaccine Technologies Licenses Immunotopes Breast, Ovarian and Prostate Cancer Antigens
5. Antigen Discovery, Inc. Awarded Grant for Chlamydia Vaccine Development
6. ImaginAb, Inc. and BZL Biologics, LLC Conclude Licensing Agreement for Imaging Rights to huJ591/Prostate-Specific Membrane Antigen (PSMA)
7. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
8. BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
9. Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes
10. Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology
11. Generex Provides Update on Spinout of Antigen Express
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Research and Markets  has announced ... 2014-2018" report to their offering. ... or Metabonomics is the scientific study of chemical ... experimental technique that is being widely used in ... small molecules that are present in blood, urine, ...
(Date:7/25/2014)... 25, 2014 According to a new ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... market is estimated at USD 161,056.5 million in 2014 ... 10.1% from 2014 to 2020, to reach an estimated ... biological drugs market is witnessing a significant growth due ...
(Date:7/25/2014)... July 25, 2014 WABC Radio show out ... with Lorry Young will be hosting California-based Vet-Stem, Inc.’s ... stem cell therapy in pets. Dr. Harman first visited ... stem cell therapy for pets suffering from osteoarthritis and other ... Veterinary Medicine industry forward. , Young has invited Dr. Harman ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 The Conferee ... for Topics for Conferee Networking. These two-hour sessions provide ... to meet and resolve problems, discuss new techniques, or ... deadline to submit a topic for consideration is August ... pittcon.org . The Conferee Networking committee will review the ...
Breaking Biology Technology:Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2
... III schizophrenia study, -- In total, nine sales contracts signed since 1 ... ... -- $3 million in revenue already locked in for FY 2009, ... a contract with an international,pharmaceutical company to provide its computerized cognitive testing,technology and associated ...
... YORK, Aug. 11 Bion Environmental,Technologies, Inc. (OTC ... that its U.S. Patent application 11/106,751 entitled "Low ... patent,application was made on April 15, 2005; upon ... and will remain in force until December,26, 2021., ...
... TELK ) reported a net loss of $13.6 million, or ... compared with a net loss of,$14.3 million, or $0.27 per ... loss for the second quarter ended June 30, 2008, includes,a ... reflected in interest and other income (expense)., For the ...
Cached Biology Technology:Sales Contracts Worth $2.3 Million Signed Since 1 July 2008 2Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 2Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 3Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 4Telik Announces Financial Results For 2008 Second Quarter 2Telik Announces Financial Results For 2008 Second Quarter 3Telik Announces Financial Results For 2008 Second Quarter 4
(Date:7/25/2014)... this false-color image from the Terra satellite show the different ... wildfires in Eastern Russia. The burn scars show up ... The wildfires have broken across the remote parts of Eastern ... image from the MODIS instrument, it is still possible ... Two recent image features noted below show the devastating number ...
(Date:7/25/2014)... have been raging this summer and some of the smoke ... In this image collected by the Moderate Resolution Imaging Spectroradiometer ... swath of smoke has descended over the Great Lakes region ... the fire image from July 23, 2014 (first image feature ... it drifts off southeastward. In the image, it is ...
(Date:7/25/2014)... link between autism and disrupted brain development is ... disease, and is largely unknown. However, thanks to ... (SFARI), George Washington University (GW) researcher Anthony-Samuel LaMantia, ... and in-depth answers to these key questions in ... professor of pharmacology and physiology at the GW ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2
... LAFAYETTE, Ind. - Just months after the soybean genome ... long-sought gene that controls the plant,s main stem growth ... of soybean plants that will allow producers to incorporate ... (Jen-Shin Ma), an assistant professor of agronomy, used the ...
... -- The National Academy of Sciences today announced the ... from 14 countries in recognition of their distinguished and ... held this morning during the business session of the ... today bring the total number of active members to ...
... , April 27 The "Great Reflation Experiment" ... the economy following the recent recession -- has been successful ... says Max Bublitz , chief strategist and portfolio manager ... of Virtus Investment Partners (Nasdaq: VRTS ), ...
Cached Biology News:Gene discovery may lead to new varieties of soybean plants 272 new members chosen by Academy 272 new members chosen by Academy 372 new members chosen by Academy 472 new members chosen by Academy 572 new members chosen by Academy 672 new members chosen by Academy 772 new members chosen by Academy 8Economic Headwinds a 'Very Big Deal' to Virtus Strategist 2Economic Headwinds a 'Very Big Deal' to Virtus Strategist 3Economic Headwinds a 'Very Big Deal' to Virtus Strategist 4
... Varioskan is a high performance ... dispenser and incubator. With the advanced ... and reliability for drug discovery assay ... for fluorescence intensity, time-resolved fluorescence and ...
Strip Removal Tool 25/Box...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
... Lambda Protein Phosphatase ... Mn2+-dependent protein phosphatase with ... threonine and tyrosine residues. ... amino-acid product of the ...
Biology Products: